FibroBiologics, Inc. Common Stock (FBLG) NASDAQ
1.16
+0.03(+2.65%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.05M |
| Enterprise Value | 7.56M |
| P/E Ratio | -0.14 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -3.15 |
| Return On Equity | -7.67 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -832,000 |
| EBITDA | -17.61M |
| Net Income | -18.65M |
| Diluted EPS | -8.4 |
Balance Sheet
| Total Cash | 1.48M |
| Total Cash/Share | 0.66 |
| Total Debt | 2.23M |
| Total Debt/Equity | 0.86 |
| Current Ratio | 1.59 |
| Book Value Per Share | 1.16 |
Price History
| 52-Week Change | -92.4 |
| 52-Week High | 19.8 |
| 52-Week Low | 0.95 |
| Moving Average 50 Days | 1.81 |
| Moving Average 200 Days | 6.28 |
Statistics
| Average Volume | 440,858 |
| Shares Outstanding | 2.1M |
| % Held by Institutions | 9.85 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 30, 2026 |
